LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 70.81 | 84.90 | 8781 | 9132 | 0.9616 | 0.9884 | MN20160318_Q02 | C08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 70.81 | 84.90 | 8931 | 9132 | 0.9780 | 0.9934 | MN20160318_Q02 | C08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 70.81 | 84.90 | 1225 | 9132 | 0.1341 | 0.4851 | MN20160318_Q02 | D15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 70.81 | 84.90 | 8332 | 9132 | 0.9124 | 0.9730 | MN20160318_Q02 | D15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 72.52 | 84.90 | 8861 | 9214 | 0.9616 | 0.9885 | MN20160318_Q02 | C08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 72.52 | 84.90 | 9150 | 9214 | 0.9930 | 0.9979 | MN20160318_Q02 | C08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 72.52 | 84.90 | 1311 | 9214 | 0.1423 | 0.4990 | MN20160318_Q02 | D15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 72.52 | 84.90 | 8580 | 9214 | 0.9312 | 0.9790 | MN20160318_Q02 | D15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 74.22 | 84.90 | 8829 | 9343 | 0.9449 | 0.9834 | MN20160318_Q02 | C08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 74.22 | 84.90 | 9300 | 9343 | 0.9954 | 0.9986 | MN20160318_Q02 | C08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 74.22 | 84.90 | 1296 | 9343 | 0.1387 | 0.4946 | MN20160318_Q02 | D15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 74.22 | 84.90 | 8850 | 9343 | 0.9472 | 0.9841 | MN20160318_Q02 | D15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 75.93 | 84.90 | 8895 | 8970 | 0.9916 | 0.9975 | MN20160318_Q02 | C08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 75.93 | 84.90 | 9430 | 8970 | 1.0512 | 1.0149 | MN20160318_Q02 | C08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 75.93 | 84.90 | 1203 | 8970 | 0.1341 | 0.4834 | MN20160318_Q02 | D15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 75.93 | 84.90 | 8975 | 8970 | 1.0005 | 1.0001 | MN20160318_Q02 | D15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 77.64 | 84.90 | 9131 | 9245 | 0.9876 | 0.9963 | MN20160318_Q02 | C08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 77.64 | 84.90 | 9547 | 9245 | 1.0326 | 1.0095 | MN20160318_Q02 | C08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 77.64 | 84.90 | 1321 | 9245 | 0.1429 | 0.5002 | MN20160318_Q02 | D15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 77.64 | 84.90 | 9195 | 9245 | 0.9945 | 0.9984 | MN20160318_Q02 | D15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 79.34 | 84.90 | 8920 | 9051 | 0.9855 | 0.9957 | MN20160318_Q02 | C08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 79.34 | 84.90 | 9699 | 9051 | 1.0715 | 1.0206 | MN20160318_Q02 | C08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 79.34 | 84.90 | 1341 | 9051 | 0.1482 | 0.5063 | MN20160318_Q02 | D15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 79.34 | 84.90 | 9382 | 9051 | 1.0365 | 1.0107 | MN20160318_Q02 | D15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 81.05 | 84.90 | 8852 | 8863 | 0.9987 | 0.9996 | MN20160318_Q02 | C08 |